730.pdf
- Type
- pdf
- Source set
- house-oversight-doj
- Pages
- 5
- Text status
- Searchable text available
- OCR confidence
- 0.8854254992319508
Original source
Extracted text
Case 1:20-cr-00330-PAE Document 730 Filed 07/14/22 Pagel1of5 U.S. Department of Justice United States Attorney Southern District of New York The Silvio J. Mollo Building One Saint Andrew's Plaza New York, New York 10007 November 13, 2021 BY EMAIL The Honorable Alison J. Nathan United States District Court Southern District of New York United States Courthouse 40 Foley Square New York, New York 10007 Re: United States v. Ghislaine Maxwell, 20 Cr. 330 (AJN) Dear Judge Nathan: The parties respectfully submit this joint letter to provide the Court with the parties’ respective positions regarding juror questionnaires completed on November 12, 2021. I. Prospective Jurors Proceeding to Voir Dire The parties agree that the following prospective jurors should proceed to voir dire: DOJ-OGR-00011401
Case 1:20-cr-00330-PAE Document 730 Filed 07/14/22 Page2of5 Page 2 Il. Prospective Jurors Excused The parties agree that the following jurors should be excused: DOJ-OGR-00011402
Case 1:20-cr-00330-PAE Document 730 Filed 07/14/22 Page3of5 Page 3 DOJ-OGR-00011403
Case 1:20-cr-00330-PAE Document 730 Page 4 II. Defense Objections Filed 07/14/22 Page 4 of 5 The following is a list of prospective jurors that the defense but not the Government believes should be excused: IV. Government Objections 568 569 | 587 | 598 | 599 609 625 631 631 568 569 587 598 509 625 645 648 652 678 686 689 The following is a list of prospective jurors that the Government but not the defense believes should be excused: DOJ-OGR-00011404
Case 1:20-cr-00330-PAE Document 730 Filed 07/14/22 Page5of5 Page 5 Cc: Defense Counsel (By email) Respectfully submitted, 585 617 620 639 656 659 662 684 DAMIAN WILLIAMS United States Attorney By: __s/ Alison Moe Lara Pomerantz Andrew Rohrbach Assistant United States Attorneys Southern District of New York DOJ-OGR-00011405
Open in the interactive archive →